xmlns:atom="http://www.w3.org/2005/Atom"
In Annex I to Directive 91/414/EEC, the following rows are added at the end of the table:
a Further details on identity and specification of active substances are provided in the review report. | ||||||
No | Common name, identification numbers | IUPAC name | Puritya | Entry into force | Expiration of inclusion | Specific provisions |
---|---|---|---|---|---|---|
‘169 | Benthiavalicarb CAS No 413615-35-7 CIPAC No 744 | [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamic acid | ≥ 910 g/kg The following manufacturing impurities are of toxicological concern and each of them must not exceed a certain amount in the technical material:
| 1 August 2008 | 31 July 2018 | Part AOnly uses as fungicide may be authorised. Part BFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on benthiavalicarb, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2008 shall be taken into account. In this overall assessment Member States must pay particular attention to:
Conditions of use shall include adequate risk mitigation measures, where appropriate. In assessing applications to authorise plant protection products containing benthiavalicarb for uses other than in glasshouses, Member States shall pay particular attention to the criteria in Article 4(1)(b), and shall ensure that any necessary data and information is provided before such an authorisation is granted. The Member States shall inform the Commission in accordance with Article 13(5) on the specification of the technical material as commercially manufactured. |
170 | Boscalid CAS No 188425-85-6 CIPAC No 673 | 2-Chloro-N-(4′-chlorobiphenyl-2-yl)nicotinamide | ≥ 960 g/kg | 1 August 2008 | 31 July 2018 | Part AOnly uses as fungicide may be authorised. Part BFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on boscalid, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2008 shall be taken into account. In this overall assessment Member States must pay particular attention
Conditions of use shall include adequate risk mitigation measures, where appropriate. |
171 | Carvone CAS No 99-49-0 (d/l mixture) CIPAC No 602 | 5-isopropenyl-2-methylcyclohex-2-en-1-one | ≥ 930 g/kg with a d/l ratio of at least 100:1 | 1 August 2008 | 31 July 2018 | Part AOnly uses as plant growth regulator may be authorised. Part BFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on carvone, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2008 shall be taken into account. In this overall assessment Member States must pay particular attention to the operator safety. Conditions of use shall include risk mitigation measures, where appropriate. |
172 | Fluoxastrobin CAS No 361377-29-9 CIPAC No 746 | (E)-{2-[6-(2-chlorophenoxy)-5-fluoropyrimidin-4-yloxy]phenyl}(5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloxime | ≥ 940 g/kg | 1 August 2008 | 31 July 2018 | Part AOnly uses as fungicide may be authorised. Part BFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on fluoxastrobin, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2008 shall be taken into account. In this overall assessment Member States must pay particular attention to:
Conditions of use shall include risk mitigation measures, where appropriate. The concerned Member States shall request the submission of:
They shall ensure that the notifier at whose request fluoxastrobin has been included in this Annex provide such studies to the Commission within two years from the entry into force of the Directive of inclusion. |
173 | Paecilomyces lilacinus (Thom) Samson 1974 strain 251 (AGAL: No 89/030550) CIPAC No 753 | Not applicable | 1 August 2008 | 31 July 2018 | Part AOnly uses as nematicide may be authorised. Part BFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on Paecilomyces lilacinus, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2008 shall be taken into account. In this overall assessment Member States must pay particular attention to:
Conditions of use shall include risk mitigation measures, where appropriate. | |
174 | Prothioconazole CAS No 178928-70-6 CIPAC No 745 | (RS)-2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-1,2,4-triazole-3-thione | ≥ 970 g/kg The following manufacturing impurities are of toxicological concern and each of them must not exceed a certain amount in the technical material:
| 1 August 2008 | 31 July 2018 | Part AOnly uses as fungicide may be authorised. Part BFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on prothioconazole, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 22 January 2008 shall be taken into account. In this overall assessment Member States must pay particular attention to:
Conditions of use shall include risk mitigation measures, where appropriate. The concerned Member States shall request the submission of:
They shall ensure that the notifier at whose request prothioconazole has been included in this Annex provide such studies to the Commission within two years from the entry into force of the Directive of inclusion.’ |